CEA-Scan antibody fragment for carcinoembryonic antigen data

In a Phase II trial in 27 patients with breast cancer, CEA-Scan demonstrated 81percent accuracy and 89 percent sensitivity, in comparison with surgical diagnosis. Results were presented at the Cancer ...